查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1702015

2025 年至 2033 年流感诊断市场报告（按产品、检测类型、流感类型、最终用户和地区划分）

Influenza Diagnostics Market Report by Product, Test Type, Type of Flu, End User, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 146 Pages | 商品交期: 2-3个工作天内

价格

2024 年全球流感诊断市场规模达 10.143 亿美元。展望未来， IMARC Group预计到 2033 年市场规模将达到 16.147 亿美元，2025-2033 年期间的成长率 (CAGR) 为 5.15%。疫苗接种力度的加大、即时检测的便利性、流感病毒研究的不断深入以及公共卫生计划带来的意识的不断提高都是推动市场发展的一些因素。

流感，俗称流感，是一种主要针对呼吸系统的病毒感染，包括鼻子、喉咙和肺部。流感诊断包括一系列免疫测定测试，旨在识别呼吸道样本中是否存在甲型和乙型流感病毒核蛋白抗原。可用的诊断方法包括快速抗原检测、逆转录聚合酶链反应 (RT-PCR)、免疫萤光测定、血清学和快速分子测定。医学界依靠这些测试来及时检测和分类流感病毒株，有助于有效的治疗决策和公共卫生管理。诊断技术的不断发展和对流感病毒的持续研究提高了这些测试的效率和可靠性。当医疗保健提供者努力对抗季节性流感爆发和潜在的流行病时，准确的诊断仍然是基石，可以实现迅速干预和明智的医疗策略。

全球市场主要受到流感疫情日益增多的推动。同时，全球对潜在流行病的担忧日益加剧，推动了对诊断能力的投资，为市场做出了重大贡献。此外，快速的技术创新提高了诊断测试的准确性和速度，对市场产生了积极的影响。除此之外，日益壮大的公众意识运动鼓励更多的人及时进行检测，从而促进市场发展。此外，不断增长的医疗保健支出支持采用先进的诊断方法，从而推动市场的发展。此外，老年人更容易感染严重流感，增加了对诊断的需求。此外，城市人口的增加导致感染率上升，需要强有力的诊断方法。频繁旅行加速了流感的传播，因此需要有效的诊断。这反过来又为市场提供了无数机会。

流感诊断市场趋势/驱动因素：

轻鬆获得医疗保健

医疗保健的便捷获取正在刺激市场成长。医疗设施可近性的提高鼓励人们及时寻求流感感染的诊断检测。当医疗保健服务易于获得时，人们更倾向于在出现症状时接受检测，以便儘早发现并采取适当的干预措施。这种及时的方法不仅有助于防止病毒传播，而且还有利于改善患者的治疗效果。此外，便捷的医疗设施支援采用各种诊断方法，包括即时检验，它可以快速提供结果，而无需大量的实验室基础设施。这种可访问的医疗保健环境为诊断製造商、医疗保健提供者和患者创造了良好的生态系统，最终促进了市场成长。

多种慢性疾病的盛行率不断上升

多种慢性疾病的发生率不断上升，正在刺激市场的发展。糖尿病、心血管疾病和呼吸系统疾病等慢性疾病会削弱免疫系统，使人们更容易感染严重的流感。随着受这些慢性疾病影响的人数不断增加，对准确和早期流感诊断的需求也日益强烈。患有慢性疾病的患者患流感併发症的风险更高，需要及时发现并采取有针对性的医疗干预措施。医疗保健提供者优先对这些脆弱人群进行检测，以减轻潜在的併发症并提供及时治疗。此外，慢性病和流感的相互关联凸显了综合诊断方法的必要性。对已有疾病的患者进行准确的流感诊断，使医疗保健专业人员能够制定治疗计划、有效管理併发症并改善患者的治疗效果。随着全球慢性病的持续增加，流感诊断的需求对于保障患有潜在疾病的个人的健康变得至关重要。这种持续的需求对市场做出了重大贡献。

人工智慧快速融合

人工智慧（AI）的快速融合正在对市场产生积极影响。人工智慧技术正在透过提高流感检测的准确性、速度和效率来彻底改变诊断能力。人工智慧演算法可以分析来自各种来源的大量资料，包括患者病史、症状和测试结果，以提供更精确和更有针对性的诊断见解。这加速了流感病例的识别，从而能够及时采取医疗干预和公共卫生应对措施。机器学习和人工智慧演算法也改善了流感爆发的预测模型。透过分析历史资料、模式和环境因素，这些技术有助于预测潜在的流感疫情，协助医疗保健组织有效地准备和分配资源。此外，人工智慧驱动的影像分析有助于评估胸部X光片等医学影像，以识别流感相关併发症并准确监测病情进展。人工智慧整合的快速发展正在改变诊断格局，为医疗专业人员提供先进的工具，以便做出更明智的决策和更精准的患者护理。这一趋势对市场贡献巨大。

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

  • 概述
  • 主要行业趋势

第五章：全球流感诊断市场

  • 市场概览
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场区隔：依产品

  • 检测试剂盒和试剂
  • 仪器
  • 其他的

第七章：市场区隔：依测试类型

  • 分子诊断测试
    • 关键部分
      • 聚合酶炼式反应
      • 等温核酸扩增试验
      • 其他分子检测
  • 传统诊断测试
    • 关键部分
      • 快速流感诊断测试
      • 病毒培养测试
      • 直接萤光抗体检测
      • 血清学检测

第八章：市场区隔：依流感类型

  • A型流感
  • B型流感
  • C型流感

第九章：市场区隔：依最终用户

  • 医院
  • 诊断实验室
  • 其他的

第十章：市场细分：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场区隔：依国家

第 11 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 12 章：价值链分析

第 13 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 14 章：价格分析

第 15 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Abbott Laboratories
    • Becton Dickinson and Company
    • Coris Bioconcept
    • Danaher Corporation
    • DiaSorin SpA
    • F. Hoffmann-La Roche Ltd (Roche Holding AG)
    • Hologic Inc.
    • Meridian Bioscience Inc.
    • Qiagen NV
    • Quidel Corporation
    • Sekisui Diagnostics LLC (Sekisui Medical Co. Ltd.)
    • Siemens Healthineers AG (Siemens AG)
Product Code: SR112025A6053

The global influenza diagnostics market size reached USD 1,014.3 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 1,614.7 Million by 2033, exhibiting a growth rate (CAGR) of 5.15% during 2025-2033. The increasing vaccination efforts, the convenience of point-of-care tests, the rising research into flu viruses, and the growing awareness through public health programs are some of the factors propelling the market.

Influenza, commonly known as the flu, is a viral infection primarily targeting the respiratory system, encompassing the nose, throat, and lungs. Influenza diagnostics encompasses an array of immunoassay tests designed to identify the presence of influenza A and B viral nucleoprotein antigens within respiratory samples. Among the diagnostic options available are rapid antigen testing, reverse transcription polymerase chain reaction (RT-PCR), immunofluorescence assays, serology, and rapid molecular assays. The medical fraternity relies on these tests to detect and categorize influenza strains promptly, aiding in effective treatment decisions and public health management. The continual evolution of diagnostic techniques and the ongoing research into influenza viruses enhance the efficiency and reliability of these tests. As healthcare providers strive to combat seasonal flu outbreaks and potential pandemics, accurate diagnostics remain a cornerstone, enabling swift intervention and informed medical strategies.

The global market is majorly driven by the increasing occurrence of flu outbreaks. In line with this, the rising global concerns about potential pandemics drive investments in diagnostic capabilities, significantly contributing to the market. Furthermore, rapid technological innovations improve the accuracy and speed of diagnostic tests, positively influencing the market. Apart from this, the growing public awareness campaigns encourage more individuals to seek timely testing, catalyzing the market. Moreover, the escalating healthcare spending supports the adoption of advanced diagnostic methods, propelling the market. Besides, elderly individuals are more susceptible to severe flu, boosting demand for diagnostics. Additionally, the increasing urban populations contribute to higher infection rates, requiring robust diagnostics. Frequent travel accelerates the spread of the flu, necessitating efficient diagnostics. This, in turn, offers numerous opportunities for the market.

Influenza Diagnostics Market Trends/Drivers:

Easy access to healthcare

The easy access to healthcare is stimulating market growth. Improved accessibility to medical facilities encourages individuals to seek timely diagnostic testing for flu infections. When healthcare services are easily reachable, people are more inclined to undergo testing at the onset of symptoms, leading to early detection and appropriate intervention. This timely approach not only aids in preventing the spread of the virus but also facilitates better patient outcomes. Furthermore, convenient access to healthcare facilities supports the adoption of various diagnostic methods, including point-of-care testing, which provides rapid results without requiring extensive laboratory infrastructure. This accessible healthcare environment creates a favorable ecosystem for diagnostic manufacturers, healthcare providers, and patients, ultimately contributing to market growth.

Increasing prevalence of several chronic diseases

The increasing prevalence of several chronic diseases is catalyzing the market. Chronic diseases, such as diabetes, cardiovascular disorders, and respiratory conditions, weaken the immune system and make individuals more susceptible to severe flu infections. As the number of individuals affected by these chronic conditions rises, the demand for accurate and early influenza diagnostics intensifies. Patients with chronic diseases are at a higher risk of complications from the flu, necessitating prompt detection and tailored medical interventions. Healthcare providers prioritize testing these vulnerable populations to mitigate potential complications and provide timely treatment. Moreover, the interconnectedness of chronic diseases and flu underscores the need for comprehensive diagnostic approaches. Accurate flu diagnosis in individuals with pre-existing conditions enables healthcare professionals to tailor treatment plans, manage complications effectively, and improve patient outcomes. As chronic diseases continue to increase globally, the demand for influenza diagnostics becomes integral in safeguarding the health of individuals with underlying conditions. This ongoing demand significantly contributes to the market.

Rapid integration of artificial intelligence

The rapid integration of artificial intelligence (AI) is favorably impacting the market. AI technologies are revolutionizing diagnostic capabilities by enhancing flu detection accuracy, speed, and efficiency. AI-powered algorithms can analyze vast amounts of data from various sources, including patient histories, symptoms, and test results, to provide more precise and tailored diagnostic insights. This accelerates the identification of flu cases, enabling timely medical interventions and public health responses. Machine learning and AI algorithms also improve predictive modeling for flu outbreaks. By analyzing historical data, patterns, and environmental factors, these technologies aid in forecasting potential flu epidemics, assisting healthcare organizations in preparing and allocating resources effectively. Additionally, AI-driven image analysis assists in evaluating medical images, such as chest X-rays, to identify flu-related complications and monitor disease progression accurately. The rapid pace of AI integration is transforming the diagnostic landscape, offering healthcare professionals advanced tools for more informed decision-making and precise patient care. This trend contributes significantly to the market.

Influenza Diagnostics Industry Segmentation:

Breakup by Product:

  • Test Kit and Reagents
  • Instruments
  • Others

Test Kit and Reagents dominates the market

Test kit and reagents form the foundation of diagnostic procedures, providing the necessary chemical components for identifying viral antigens and antibodies in patient samples. These kits enable healthcare professionals to swiftly and accurately diagnose influenza infections, facilitating timely medical interventions and public health responses. The continuous innovation in test kit technology, including improved sensitivity and specificity, contributes to heightened accuracy in flu detection.

On the other hand, instruments encompass the equipment for processing and analyzing samples, automating diagnostic workflows, and delivering reliable results. These instruments, ranging from PCR machines to automated immunoassay platforms, streamline the testing process, reduce human errors, and enhance the overall efficiency of diagnostics.

Breakup by Test Type:

  • Molecular Diagnostic Tests
  • Polymerase Chain Reaction
  • Isothermal Nucleic Acid Amplification Tests
  • Other Molecular Tests
  • Traditional Diagnostic Tests
  • Rapid Influenza Diagnostic Tests
  • Viral Culture Tests
  • Direct Fluorescent Antibody Test
  • Serological Tests

Traditional Diagnostic Test dominates the market

Traditional diagnostic tests encompass methods like rapid antigen testing and immunofluorescence assays. While they may not offer the same level of sensitivity as molecular tests, they provide rapid results, making them invaluable in scenarios where swift diagnosis is critical for patient management and public health responses.

Molecular diagnostic tests on the other hand, utilize advanced molecular techniques such as polymerase chain reaction (PCR) and nucleic acid amplification to detect the influenza virus's genetic material directly. These tests offer high sensitivity and specificity, enabling early and accurate identification of viral infections. The increasing adoption of molecular diagnostic tests is driven by their ability to detect multiple flu strains and their potential to differentiate between seasonal and novel influenza viruses.

Breakup by Type of Flu:

  • Type A Flu
  • Type B Flu
  • Type C Flu

Type A Flu dominates the market

""Type A Flu"" includes various influenza viruses, some responsible for seasonal flu outbreaks and potential pandemics. Accurate differentiation of specific Type A strains is essential for targeted treatment and surveillance efforts.

Furthermore, ""Type B Flu"" encompasses a distinct group of viruses contributing to seasonal flu epidemics. Detecting and categorizing Type B strains aid in tailoring medical interventions and vaccine development to mitigate flu-related complications.

Moreover, ""Type C Flu,"" although typically milder, still requires accurate diagnosis for effective patient management. While it is less likely to cause large outbreaks, its inclusion highlights the comprehensive approach to influenza diagnostics.

Breakup by End User:

  • Hospitals
  • Diagnostic Laboratories
  • Others

Hospitals dominates the market

Hospitals encompass a significant portion of the market demand, offering immediate access to diagnostic services for patients with flu-like symptoms. Timely diagnosis within hospitals enables rapid treatment decisions and infection control measures, which are crucial for managing patient health and preventing virus spread within healthcare facilities.

Furthermore, diagnostic Laboratories are specialized hubs for accurate and thorough flu testing. These laboratories often employ advanced equipment and experienced personnel to conduct comprehensive diagnostic procedures. By focusing on high-quality diagnostics, they support healthcare providers in delivering accurate results, essential for effective patient management and public health interventions.

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

North America exhibits a clear dominance, accounting for the largest market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America's emphasis on research and innovation fosters the development of cutting-edge diagnostic technologies and methodologies. This region leads in adopting advanced testing solutions that enhance the accuracy and efficiency of flu detection. Its high prevalence of chronic diseases and respiratory conditions underscores the need for accurate influenza diagnostics. With a focus on timely detection, healthcare providers in North America rely on a wide range of diagnostic tests to ensure prompt treatment and prevent escalating flu-related complications.

Government initiatives, awareness campaigns, and strong healthcare policies drive the demand for influenza diagnostics. The region's robust public health infrastructure emphasizes the importance of accurate diagnostics in managing seasonal outbreaks and potential pandemics. The prevalence of international travel and globalization also heightens the demand for accurate flu testing in North America, as early detection becomes crucial in preventing the importation and spread of viral strains. The region's commitment to accurate and timely diagnostics positions it as a key driver in shaping the industry's expansion.

Competitive Landscape:

Top companies are bolstering the market through their innovative approaches and expertise. These companies leverage their resources and research capabilities to drive market expansion. They invest significantly in research and development, leading to the creation of advanced diagnostic technologies. These innovations, including AI-powered platforms and rapid testing solutions, enhance the accuracy and efficiency of flu detection. Top companies collaborate with healthcare providers and institutions to ensure widespread product access. These partnerships facilitate the integration of cutting-edge diagnostic solutions into existing healthcare systems, expanding market reach. Moreover, these companies often conduct awareness campaigns to educate healthcare professionals and the public about the importance of timely flu testing. These efforts drive increased demand for accurate diagnostics. Furthermore, their global presence and distribution networks enable them to provide essential diagnostic tools to regions with varying levels of healthcare infrastructure, contributing to overall market growth.

The report has provided a comprehensive analysis of the competitive landscape in the influenza diagnostics market. Detailed profiles of all major companies have also been provided.

  • Abbott Laboratories
  • Becton Dickinson and Company
  • Coris Bioconcept
  • Danaher Corporation
  • DiaSorin S.p.A.
  • F. Hoffmann-La Roche Ltd (Roche Holding AG)
  • Hologic Inc.
  • Meridian Bioscience Inc.
  • Qiagen N.V
  • Quidel Corporation
  • Sekisui Diagnostics LLC (Sekisui Medical Co. Ltd.)
  • Siemens Healthineers AG (Siemens AG).

Key Questions Answered in This Report

  • 1.What was the size of the global influenza diagnostics market in 2024?
  • 2.What is the expected growth rate of the global influenza diagnostics market during 2025-2033?
  • 3.What are the key factors driving the global influenza diagnostics market?
  • 4.What has been the impact of COVID-19 on the global influenza diagnostics market?
  • 5.What is the breakup of the global influenza diagnostics market based on the product?
  • 6.What is the breakup of the global influenza diagnostics market based on the test type?
  • 7.What is the breakup of the global influenza diagnostics market based on type of flu?
  • 8.What is the breakup of the global influenza diagnostics market based on the end user?
  • 9.What are the key regions in the global influenza diagnostics market?
  • 10.Who are the key players/companies in the global influenza diagnostics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Influenza Diagnostics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Test Kit and Reagents
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Instruments
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Others
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Test Type

  • 7.1 Molecular Diagnostic Tests
    • 7.1.1 Market Trends
    • 7.1.2 Key Segments
      • 7.1.2.1 Polymerase Chain Reaction
      • 7.1.2.2 Isothermal Nucleic Acid Amplification Tests
      • 7.1.2.3 Other Molecular Tests
    • 7.1.3 Market Forecast
  • 7.2 Traditional Diagnostic Tests
    • 7.2.1 Market Trends
    • 7.2.2 Key Segments
      • 7.2.2.1 Rapid Influenza Diagnostic Tests
      • 7.2.2.2 Viral Culture Tests
      • 7.2.2.3 Direct Fluorescent Antibody Test
      • 7.2.2.4 Serological Tests
    • 7.2.3 Market Forecast

8 Market Breakup by Type of Flu

  • 8.1 Type A Flu
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Type B Flu
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Type C Flu
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Diagnostic Laboratories
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Others
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Abbott Laboratories
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Becton Dickinson and Company
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Coris Bioconcept
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4 Danaher Corporation
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 DiaSorin S.p.A.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 F. Hoffmann-La Roche Ltd (Roche Holding AG)
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 SWOT Analysis
    • 15.3.7 Hologic Inc.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Meridian Bioscience Inc.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Qiagen N.V
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Quidel Corporation
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Sekisui Diagnostics LLC (Sekisui Medical Co. Ltd.)
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
    • 15.3.12 Siemens Healthineers AG (Siemens AG)
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
      • 15.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Influenza Diagnostics Market: Major Drivers and Challenges
  • Figure 2: Global: Influenza Diagnostics Market: Sales Value (in Million USD), 2019-2024
  • Figure 3: Global: Influenza Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 4: Global: Influenza Diagnostics Market: Breakup by Product (in %), 2024
  • Figure 5: Global: Influenza Diagnostics Market: Breakup by Test Type (in %), 2024
  • Figure 6: Global: Influenza Diagnostics Market: Breakup by Type of Flu (in %), 2024
  • Figure 7: Global: Influenza Diagnostics Market: Breakup by End User (in %), 2024
  • Figure 8: Global: Influenza Diagnostics Market: Breakup by Region (in %), 2024
  • Figure 9: Global: Influenza Diagnostics (Test Kit and Reagents) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Influenza Diagnostics (Test Kit and Reagents) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Influenza Diagnostics (Instruments) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Influenza Diagnostics (Instruments) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Influenza Diagnostics (Other Products) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Influenza Diagnostics (Other Products) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Influenza Diagnostics (Molecular Diagnostic Tests) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Influenza Diagnostics (Molecular Diagnostic Tests) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Influenza Diagnostics (Traditional Diagnostic Tests) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Influenza Diagnostics (Traditional Diagnostic Tests) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Influenza Diagnostics (Type A Flu) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Influenza Diagnostics (Type A Flu) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Influenza Diagnostics (Type B Flu) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Influenza Diagnostics (Type B Flu) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: Influenza Diagnostics (Type C Flu) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: Influenza Diagnostics (Type C Flu) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: Influenza Diagnostics (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Global: Influenza Diagnostics (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Global: Influenza Diagnostics (Diagnostic Laboratories) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Global: Influenza Diagnostics (Diagnostic Laboratories) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Global: Influenza Diagnostics (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Global: Influenza Diagnostics (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: North America: Influenza Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: North America: Influenza Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: United States: Influenza Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: United States: Influenza Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: Canada: Influenza Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: Canada: Influenza Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: Asia-Pacific: Influenza Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: Asia-Pacific: Influenza Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: China: Influenza Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: China: Influenza Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: Japan: Influenza Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: Japan: Influenza Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: India: Influenza Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: India: Influenza Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: South Korea: Influenza Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: South Korea: Influenza Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: Australia: Influenza Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: Australia: Influenza Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: Indonesia: Influenza Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: Indonesia: Influenza Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: Others: Influenza Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: Others: Influenza Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: Europe: Influenza Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: Europe: Influenza Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: Germany: Influenza Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: Germany: Influenza Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: France: Influenza Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: France: Influenza Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: United Kingdom: Influenza Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: United Kingdom: Influenza Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: Italy: Influenza Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: Italy: Influenza Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: Spain: Influenza Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: Spain: Influenza Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: Russia: Influenza Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: Russia: Influenza Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: Others: Influenza Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: Others: Influenza Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: Latin America: Influenza Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: Latin America: Influenza Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: Brazil: Influenza Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 72: Brazil: Influenza Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: Mexico: Influenza Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 74: Mexico: Influenza Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Others: Influenza Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 76: Others: Influenza Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Middle East and Africa: Influenza Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 78: Middle East and Africa: Influenza Diagnostics Market: Breakup by Country (in %), 2024
  • Figure 79: Middle East and Africa: Influenza Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 80: Global: Influenza Diagnostics Industry: SWOT Analysis
  • Figure 81: Global: Influenza Diagnostics Industry: Value Chain Analysis
  • Figure 82: Global: Influenza Diagnostics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Influenza Diagnostics Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Influenza Diagnostics Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 3: Global: Influenza Diagnostics Market Forecast: Breakup by Test Type (in Million USD), 2025-2033
  • Table 4: Global: Influenza Diagnostics Market Forecast: Breakup by Type of Flu (in Million USD), 2025-2033
  • Table 5: Global: Influenza Diagnostics Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 6: Global: Influenza Diagnostics Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 7: Global: Influenza Diagnostics Market: Competitive Structure
  • Table 8: Global: Influenza Diagnostics Market: Key Players